Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.66 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 51.27.
Market Cap
9.66T
Revenue
4.67T
Profits
188.44B
PE Ratio
51.27
Profit Margin
4.04%
Dividend Yield
0.38%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.15T | 4.19% | 1,861,751 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 625.68B | 2.30% | 3,506,083 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 513.22B | 2.74% | 2,385,215 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 376.81B | 3.18% | 4,407,923 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 365.71B | 3.20% | 3,851,722 | 66.57B |
| 6 | NVS | Novartis AG | 298.02B | 2.25% | 830,037 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 269.42B | 2.82% | 1,845,441 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 254.72B | 1.40% | 2,044,604 | 46.34B |
| 9 | AMGN | Amgen Inc. | 235.52B | 2.52% | 969,218 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 193.53B | 1.97% | 2,998,686 | 30.46B |
| 11 | ABT | Abbott Laboratories | 177.85B | -1.23% | 5,943,895 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 176.68B | 2.08% | 5,815,833 | 50.34B |
| 13 | PFE | Pfizer Inc. | 172.24B | 2.65% | 19,739,424 | 63.70B |
| 14 | DHR | Danaher Corporation | 157.76B | -0.01% | 4,772,779 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 154.83B | 1.17% | 1,165,661 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 129.53B | 1.81% | 488,916 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.89B | 4.76% | 6,135,515 | 49.19B |
| 18 | CVS | CVS Health Corporation | 120.35B | 1.53% | 3,308,644 | 412.65B |
| 19 | MCK | McKesson Corporation | 119.13B | 1.13% | 366,660 | 410.98B |
| 20 | SYK | Stryker Corporation | 116.74B | 2.15% | 1,344,110 | 25.84B |
| 21 | MDT | Medtronic plc | 115.67B | 1.85% | 4,970,121 | 37.54B |
| 22 | SNY | Sanofi | 103.53B | 4.54% | 2,329,191 | 55.89B |
| 23 | GSK | GSK plc | 101.62B | 1.46% | 2,213,931 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 100.63B | 2.18% | 706,243 | 78.01B |
| 25 | MRNA | Moderna, Inc. | 96.20B | 6.20% | 11,183,929 | 2.23B |
| 26 | ELV | Elevance Health, Inc. | 95.14B | 1.97% | 665,998 | 201.11B |
| 27 | CI | The Cigna Group | 80.85B | 2.51% | 509,371 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 79.58B | 1.91% | 323,863 | 15.53B |
| 29 | BSX | Boston Scientific Corporation | 65.95B | 1.02% | 10,164,926 | 21.00B |
| 30 | COR | Cencora, Inc. | 65.32B | 0.67% | 362,444 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 65.06B | 2.30% | 2,025,784 | 28.42B |
| 32 | NTRA | Natera, Inc. | 58.91B | 2.32% | 469,401 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 58.91B | 0.69% | 560,670 | 254.25B |
| 34 | ARGX | argenx SE | 54.56B | 6.57% | 330,054 | 5.32B |
| 35 | BDX | Becton, Dickinson and Company | 52.68B | 1.40% | 435,543 | 22.48B |
| 36 | HUM | Humana Inc. | 51.49B | 3.33% | 439,803 | 145.68B |
| 37 | VEEV | Veeva Systems Inc. | 51.14B | -0.31% | 753,419 | 3.46B |
| 38 | EW | Edwards Lifesciences Corporation | 50.67B | 0.78% | 703,043 | 6.51B |
| 39 | A | Agilent Technologies, Inc. | 48.88B | 2.04% | 816,276 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 48.03B | -0.22% | 2,145,131 | 17.32B |
| 41 | MDLN | Medline Inc. | 46.69B | 0.91% | 6,146,308 | 29.94B |
| 42 | HLN | Haleon plc | 44.34B | 0.10% | 13,130,625 | 14.80B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 43.83B | 0.10% | 206,521 | 4.55B |
| 44 | WAT | Waters Corporation | 43.77B | 2.58% | 344,921 | 4.64B |
| 45 | IQV | IQVIA Holdings Inc. | 43.52B | -0.55% | 703,562 | 16.98B |
| 46 | ONC | BeOne Medicines AG | 43.46B | 3.26% | 274,122 | 6.13B |
| 47 | RVMD | Revolution Medicines, Inc. | 41.88B | 7.28% | 1,607,994 | - |
| 48 | ILMN | Illumina, Inc. | 40.70B | 2.61% | 761,493 | 4.49B |
| 49 | BIIB | Biogen Inc. | 35.89B | 4.03% | 861,807 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 35.76B | 3.19% | 930,002 | 2.54B |
| 51 | CNC | Centene Corporation | 34.78B | 2.58% | 1,511,936 | 180.30B |
| 52 | RMD | ResMed Inc. | 34.46B | 2.20% | 651,595 | 5.65B |
| 53 | ALC | Alcon Inc. | 33.46B | 2.42% | 580,742 | 10.86B |
| 54 | ZTS | Zoetis Inc. | 32.92B | 0.10% | 1,999,760 | 9.53B |
| 55 | MTD | Mettler-Toledo International Inc. | 32.68B | 0.31% | 109,618 | 4.13B |
| 56 | DXCM | DexCom, Inc. | 32.35B | -0.28% | 976,408 | 4.97B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.73B | 0.71% | 1,113,594 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.96B | -0.84% | 830,286 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.27B | 0.94% | 324,440 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 26.03B | 0.66% | 245,663 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 26.01B | 0.33% | 416,741 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 25.62B | 1.98% | 546,747 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 25.38B | 1.24% | 1,897,466 | 7.53M |
| 64 | GMAB | Genmab A/S | 23.87B | 2.16% | 1,991,152 | 4.13B |
| 65 | UTHR | United Therapeutics Corporation | 23.63B | 1.44% | 265,444 | 3.15B |
| 66 | INCY | Incyte Corporation | 23.60B | 2.83% | 477,294 | 5.82B |
| 67 | BNTX | BioNTech SE | 22.66B | 1.11% | 1,000,437 | 3.03B |
| 68 | THC | Tenet Healthcare Corporation | 21.95B | 2.32% | 190,415 | 21.81B |
| 69 | STE | STERIS plc | 21.86B | 1.00% | 243,219 | 6.04B |
| 70 | GH | Guardant Health, Inc. | 21.75B | 2.67% | 717,905 | 1.18B |
| 71 | VTRS | Viatris Inc. | 21.20B | 1.10% | 4,982,620 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.85B | 0.18% | 1,449,677 | 1.14B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.26B | 0.78% | 556,458 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 17.54B | 4.13% | 759,354 | 2.91B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.22B | -0.41% | 195,279 | 2.78B |
| 76 | EXEL | Exelixis, Inc. | 15.85B | 2.08% | 1,061,226 | 2.44B |
| 77 | ASND | Ascendis Pharma A/S | 15.38B | 1.84% | 179,939 | 1.20B |
| 78 | CRL | Charles River Laboratories International, Inc. | 14.94B | 4.31% | 573,038 | 4.00B |
| 79 | SOLV | Solventum Corporation | 14.69B | 1.46% | 293,460 | 8.31B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.36B | 3.12% | 599,729 | 3.37B |
| 81 | HALO | Halozyme Therapeutics, Inc. | 14.11B | 1.45% | 1,381,493 | 1.66B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 13.81B | 2.10% | 312,366 | 4.60B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.26B | -0.18% | 1,449,506 | 713.07M |
| 84 | ICLR | ICON Public Limited Company | 13.06B | 0.70% | 446,401 | 8.29B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 12.99B | 1.73% | 499,319 | 14.37B |
| 86 | SMMT | Summit Therapeutics Inc. | 12.78B | 2.63% | 3,769,337 | - |
| 87 | PEN | Penumbra, Inc. | 12.77B | 0.52% | 203,265 | 1.50B |
| 88 | BAX | Baxter International Inc. | 12.54B | -2.92% | 8,692,882 | 11.47B |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.49B | 3.10% | 310,961 | 830.81M |
| 90 | TEM | Tempus AI, Inc. | 12.41B | 6.90% | 2,541,397 | 1.43B |
| 91 | SNN | Smith & Nephew plc | 12.22B | 1.56% | 562,293 | 6.30B |
| 92 | EHC | Encompass Health Corporation | 11.91B | -0.84% | 603,783 | 6.21B |
| 93 | MOH | Molina Healthcare, Inc. | 11.40B | 4.12% | 450,912 | 42.47B |
| 94 | ELAN | Elanco Animal Health Incorporated | 11.39B | -2.98% | 5,281,651 | 5.02B |
| 95 | TECH | Bio-Techne Corporation | 11.38B | 0.08% | 2,301,244 | 1.22B |
| 96 | FMS | Fresenius Medical Care AG | 11.35B | -2.19% | 4,949,383 | 22.19B |
| 97 | AVTR | Avantor, Inc. | 11.30B | 2.58% | 4,789,524 | 6.56B |
| 98 | COO | The Cooper Companies, Inc. | 11.21B | 1.32% | 897,815 | 4.24B |
| 99 | DVA | DaVita Inc. | 11.17B | -6.35% | 1,361,227 | 14.01B |
| 100 | RDY | Dr. Reddy's Laboratories Limited | 11.07B | 1.49% | 2,603,726 | 3.50B |
| 101 | UHS | Universal Health Services, Inc. | 10.91B | 1.59% | 154,678 | 18.11B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | 2.51% | 1,530,437 | 3.41B |
| 103 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.72B | 3.79% | 207,237 | 1.28B |
| 104 | ALGN | Align Technology, Inc. | 10.63B | 0.38% | 461,371 | 4.14B |
| 105 | GMED | Globus Medical, Inc. | 10.56B | 3.98% | 694,697 | 3.14B |
| 106 | PCVX | Vaxcyte, Inc. | 10.50B | 4.73% | 1,173,647 | - |
| 107 | OSCR | Oscar Health, Inc. | 10.44B | 4.06% | 1,945,555 | 15.32B |
| 108 | GKOS | Glaukos Corporation | 10.32B | 4.82% | 247,140 | 612.84M |
| 109 | QGEN | Qiagen N.V. | 10.17B | 5.69% | 7,710,443 | 2.10B |
| 110 | RGEN | Repligen Corporation | 10.13B | 1.75% | 432,124 | 785.10M |
| 111 | ENSG | The Ensign Group, Inc. | 10.08B | 0.80% | 141,255 | 5.49B |
| 112 | PODD | Insulet Corporation | 9.94B | 0.94% | 666,473 | 3.05B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.64B | 1.68% | 73,001 | 440.48M |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 9.51B | 0.84% | 106,174 | 2.59B |
| 115 | TXG | 10x Genomics, Inc. | 9.47B | 3.96% | 1,600,633 | 616.91M |
| 116 | KYMR | Kymera Therapeutics, Inc. | 9.42B | 4.84% | 326,241 | 105.00M |
| 117 | HSIC | Henry Schein, Inc. | 9.41B | 0.57% | 557,187 | 13.60B |
| 118 | IBRX | ImmunityBio, Inc. | 9.36B | 4.93% | 8,515,807 | 165.79M |
| 119 | TWST | Twist Bioscience Corporation | 9.24B | 5.46% | 1,299,684 | 431.80M |
| 120 | CYTK | Cytokinetics, Incorporated | 8.92B | 2.44% | 493,393 | 67.67M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.92B | 2.55% | 376,091 | 281.99M |
| 122 | CAI | Caris Life Sciences, Inc. | 8.83B | 1.73% | 1,758,416 | 989.61M |
| 123 | HNGE | Hinge Health, Inc. | 8.67B | 3.32% | 1,137,136 | 720.06M |
| 124 | SYRE | Spyre Therapeutics, Inc. | 8.66B | 9.37% | 830,610 | - |
| 125 | ABVX | ABIVAX Société Anonyme | 8.65B | 6.25% | 1,216,551 | 5.33M |
| 126 | BRKR | Bruker Corporation | 8.56B | 1.52% | 498,948 | 3.50B |
| 127 | AXSM | Axsome Therapeutics, Inc. | 8.38B | 2.71% | 299,394 | 776.57M |
| 128 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.34B | 3.22% | 884,280 | 669.50M |
| 129 | ATR | AptarGroup, Inc. | 7.95B | 0.32% | 123,703 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.89B | 2.52% | 206,856 | 1.36B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.70B | 1.88% | 476,163 | 799.54M |
| 132 | PACS | PACS Group, Inc. | 7.54B | 3.90% | 307,290 | 5.55B |
| 133 | PRAX | Praxis Precision Medicines, Inc. | 7.50B | 3.28% | 338,660 | 7.46M |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.47B | 1.32% | 828,235 | 874.09M |
| 135 | ALKS | Alkermes plc | 7.44B | 3.14% | 1,075,191 | 1.67B |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.90B | 5.06% | 7,189,810 | 2.58B |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 6.88B | 2.01% | 1,032,682 | 3.12B |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 6.74B | 4.71% | 6,772,228 | 324.97M |
| 139 | GRFS | Grifols, S.A. | 6.70B | -0.92% | 217,224 | 8.48B |
| 140 | CHE | Chemed Corporation | 6.67B | 0.84% | 44,203 | 2.60B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.54B | 0.30% | 749,191 | 1.56B |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.43B | 3.71% | 423,134 | 840.85M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.23B | 2.62% | 661,396 | 239.92M |
| 144 | BLTE | Belite Bio, Inc | 6.21B | 4.70% | 95,453 | - |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.17B | 4.08% | 70,880 | 290.54M |
| 146 | BLCO | Bausch + Lomb Corporation | 6.06B | 2.17% | 173,394 | 5.32B |
| 147 | DOCS | Doximity, Inc. | 5.99B | 6.92% | 2,375,465 | 655.57M |
| 148 | IMVT | Immunovant, Inc. | 5.95B | 4.34% | 748,867 | - |
| 149 | KOD | Kodiak Sciences Inc. | 5.95B | 3.86% | 470,372 | - |
| 150 | GRAL | GRAIL, Inc. | 5.62B | 2.87% | 358,861 | 165.26M |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 5.53B | 3.64% | 234,407 | 618.07M |
| 152 | WAY | Waystar Holding Corp. | 5.53B | 3.11% | 1,318,410 | 1.21B |
| 153 | TFX | Teleflex Incorporated | 5.52B | 0.47% | 219,722 | 2.25B |
| 154 | RDNT | RadNet, Inc. | 5.52B | 1.24% | 101,802 | 2.27B |
| 155 | CGON | CG Oncology, Inc. | 5.51B | 3.65% | 279,176 | 6.23M |
| 156 | MMSI | Merit Medical Systems, Inc. | 5.42B | 0.92% | 232,225 | 1.58B |
| 157 | COGT | Cogent Biosciences, Inc. | 5.41B | 3.90% | 1,213,829 | - |
| 158 | MANE | Veradermics, Incorporated | 5.41B | 5.89% | 624,680 | - |
| 159 | HAE | Haemonetics Corporation | 5.40B | 0.02% | 221,482 | 1.35B |
| 160 | ORKA | Oruka Therapeutics, Inc. | 5.26B | 6.58% | 351,173 | - |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.25B | 2.15% | 374,855 | 1.01B |
| 162 | STVN | Stevanato Group S.p.A. | 5.16B | -0.60% | 131,419 | 1.40B |
| 163 | ERAS | Erasca, Inc. | 5.14B | 7.93% | 1,971,039 | - |
| 164 | SHC | Sotera Health Company | 5.13B | 1.98% | 749,220 | 1.22B |
| 165 | SRRK | Scholar Rock Holding Corporation | 5.07B | 3.43% | 935,500 | - |
| 166 | RGC | Regencell Bioscience Holdings Limited | 5.05B | 1.29% | 325,068 | - |
| 167 | TVTX | Travere Therapeutics, Inc. | 4.95B | 3.92% | 725,283 | 591.33M |
| 168 | MMED | MiniMed Group, Inc. | 4.94B | -1.29% | 4,904,116 | 3.22B |
| 169 | CON | Concentra Group Holdings Parent, Inc. | 4.93B | 1.31% | 428,216 | 2.29B |
| 170 | BLLN | BillionToOne, Inc. | 4.90B | 2.82% | 157,391 | 397.41M |
| 171 | CRSP | CRISPR Therapeutics AG | 4.86B | 0.42% | 1,558,166 | 13.39M |
| 172 | HTFL | HeartFlow, Inc. | 4.82B | 8.60% | 1,478,417 | 212.07M |
| 173 | DFTX | Definium Therapeutics, Inc. | 4.74B | 6.95% | 1,150,333 | - |
| 174 | LFST | LifeStance Health Group, Inc. | 4.69B | 4.38% | 771,539 | 1.58B |
| 175 | OPCH | Option Care Health, Inc. | 4.69B | 0.26% | 1,708,162 | 5.69B |
| 176 | DNTH | Dianthus Therapeutics, Inc. | 4.42B | 5.96% | 747,211 | 1.90M |
| 177 | LIVN | LivaNova PLC | 4.41B | 2.33% | 172,788 | 1.47B |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.34B | 5.43% | 947,288 | - |
| 179 | ITGR | Integer Holdings Corporation | 4.31B | 0.01% | 502,988 | 1.84B |
| 180 | TNGX | Tango Therapeutics, Inc. | 4.19B | 5.52% | 1,240,635 | 53.81M |
| 181 | ARQT | Arcutis Biotherapeutics, Inc. | 4.09B | 1.94% | 2,099,225 | 463.98M |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 4.05B | 1.45% | 652,198 | 1.33B |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.05B | 8.05% | 845,423 | 10.35M |
| 184 | ICUI | ICU Medical, Inc. | 4.03B | 0.01% | 84,700 | 2.16B |
| 185 | ADPT | Adaptive Biotechnologies Corporation | 3.92B | 2.59% | 565,619 | 308.08M |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.89B | 3.82% | 187,698 | 890.79M |
| 187 | NHC | National HealthCare Corporation | 3.84B | 2.47% | 64,472 | 1.56B |
| 188 | ABCL | AbCellera Biologics Inc. | 3.79B | -1.93% | 2,354,906 | 66.17M |
| 189 | IRTC | iRhythm Holdings, Inc. | 3.77B | 4.29% | 210,801 | 825.34M |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.69B | 8.83% | 160,688 | 1.19M |
| 191 | LEGN | Legend Biotech Corporation | 3.69B | 2.09% | 576,531 | 1.27B |
| 192 | NVST | Envista Holdings Corporation | 3.66B | 0.82% | 2,795,502 | 2.86B |
| 193 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.64B | 6.07% | 855,566 | -665.00K |
| 194 | CDNA | CareDx, Inc. | 3.64B | 4.84% | 927,065 | 458.09M |
| 195 | OGN | Organon & Co. | 3.61B | 0.04% | 1,259,856 | 6.13B |
| 196 | VCYT | Veracyte, Inc. | 3.61B | 2.42% | 297,362 | 561.90M |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.54B | 4.22% | 435,979 | 7.50M |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.50B | 2.73% | 839,415 | 1.14B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.42B | 4.88% | 477,062 | 234.13M |
| 200 | PBLS | Parabilis Medicines, Inc. | 3.23B | 3.27% | 620,806 | 148.00K |
| 201 | LQDA | Liquidia Corporation | 3.23B | 5.80% | 1,972,355 | 450.91M |
| 202 | WRBY | Warby Parker Inc. | 3.15B | 2.08% | 1,507,964 | 911.61M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | 2.16% | 389,959 | 606.33M |
| 204 | VKTX | Viking Therapeutics, Inc. | 3.08B | 5.47% | 2,696,992 | - |
| 205 | DNLI | Denali Therapeutics Inc. | 3.08B | 6.82% | 1,064,219 | 3.60M |
| 206 | RCUS | Arcus Biosciences, Inc. | 3.08B | 9.08% | 4,696,325 | 117.00M |
| 207 | DYN | Dyne Therapeutics, Inc. | 3.06B | 7.62% | 1,852,297 | - |
| 208 | IRON | Disc Medicine, Inc. | 3.05B | 0.49% | 1,149,420 | - |
| 209 | ELVN | Enliven Therapeutics, Inc. | 3.00B | 5.71% | 758,596 | - |
| 210 | PRVA | Privia Health Group, Inc. | 2.94B | 2.72% | 310,724 | 2.36B |
| 211 | ATRC | AtriCure, Inc. | 2.93B | 3.84% | 182,662 | 569.62M |
| 212 | CELC | Celcuity Inc. | 2.93B | 4.70% | 656,370 | - |
| 213 | ACHC | Acadia Healthcare Company, Inc. | 2.92B | 3.88% | 489,716 | 3.37B |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.85B | 4.69% | 2,128,839 | 701.94M |
| 215 | ZLAB | Zai Lab Limited | 2.82B | 4.38% | 508,726 | 449.61M |
| 216 | AVAH | Aveanna Healthcare Holdings Inc. | 2.78B | 2.49% | 667,794 | 2.60B |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.67B | 4.86% | 158,664 | 1.46B |
| 218 | HCM | HUTCHMED (China) Limited | 2.61B | 3.88% | 31,532 | 549.12M |
| 219 | MBX | MBX Biosciences, Inc. | 2.60B | 3.01% | 550,277 | - |
| 220 | TMDX | TransMedics Group, Inc. | 2.60B | 4.68% | 704,804 | 668.47M |
| 221 | NAMS | NewAmsterdam Pharma Company N.V. | 2.57B | 4.89% | 505,856 | 7.12M |
| 222 | NEOG | Neogen Corporation | 2.56B | 0.95% | 701,370 | 884.00M |
| 223 | VRDN | Viridian Therapeutics, Inc. | 2.53B | 7.24% | 1,051,858 | 71.13M |
| 224 | ADMA | ADMA Biologics, Inc. | 2.51B | 1.40% | 1,197,550 | 512.28M |
| 225 | CLOV | Clover Health Investments, Corp. | 2.49B | 5.63% | 1,953,710 | 2.48B |
| 226 | BEAM | Beam Therapeutics Inc. | 2.49B | 3.02% | 700,242 | 156.04M |
| 227 | PGEN | Precigen, Inc. | 2.46B | 3.30% | 3,392,984 | 85.72M |
| 228 | BHC | Bausch Health Companies Inc. | 2.40B | 1.50% | 1,046,409 | 10.85B |
| 229 | BKD | Brookdale Senior Living Inc. | 2.40B | 1.83% | 1,865,034 | 2.93B |
| 230 | CLDX | Celldex Therapeutics, Inc. | 2.39B | 2.46% | 517,860 | 158.00K |
| 231 | SLS | SELLAS Life Sciences Group, Inc. | 2.36B | 11.25% | 5,819,513 | - |
| 232 | SUPN | Supernus Pharmaceuticals, Inc. | 2.35B | 1.43% | 550,095 | 830.44M |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | -0.69% | 153,809 | 1.10B |
| 234 | UFPT | UFP Technologies, Inc. | 2.26B | -0.34% | 82,383 | 631.64M |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.25B | 2.85% | 326,481 | 959.90M |
| 236 | PRGO | Perrigo Company plc | 2.24B | 0.12% | 734,150 | 4.14B |
| 237 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.46% | 279,569 | 311.51M |
| 238 | PGNY | Progyny, Inc. | 2.21B | 3.63% | 493,795 | 1.31B |
| 239 | MD | Pediatrix Medical Group, Inc. | 2.20B | 1.47% | 182,073 | 1.95B |
| 240 | PHVS | Pharvaris N.V. | 2.18B | 4.43% | 575,060 | - |
| 241 | RXRX | Recursion Pharmaceuticals, Inc. | 2.17B | 0.69% | 13,563,528 | 54.86M |
| 242 | AGIO | Agios Pharmaceuticals, Inc. | 2.17B | 4.04% | 796,351 | 98.34M |
| 243 | VERA | Vera Therapeutics, Inc. | 2.15B | 3.28% | 575,410 | - |
| 244 | NEO | NeoGenomics, Inc. | 2.15B | 2.01% | 407,749 | 766.30M |
| 245 | FTRE | Fortrea Holdings Inc. | 2.15B | 0.80% | 983,430 | 2.68B |
| 246 | ADUS | Addus HomeCare Corporation | 2.15B | 1.90% | 59,265 | 1.48B |
| 247 | AXGN | Axogen, Inc. | 2.13B | 3.25% | 447,953 | 251.17M |
| 248 | VCEL | Vericel Corporation | 2.07B | 0.22% | 213,721 | 306.30M |
| 249 | SRPT | Sarepta Therapeutics, Inc. | 2.07B | 10.55% | 1,581,722 | 1.97B |
| 250 | TRLV | Trulieve Cannabis Corp. | 2.07B | 4.57% | 596,141 | 1.14B |
| 251 | IMNM | Immunome, Inc. | 2.06B | 8.41% | 1,115,433 | 4.02M |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.06B | 1.78% | 146,193 | 898.74M |
| 253 | WGS | GeneDx Holdings Corp. | 2.05B | 3.92% | 223,019 | 454.43M |
| 254 | XERS | Xeris Biopharma Holdings, Inc. | 2.03B | 1.74% | 1,516,085 | 335.41M |
| 255 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.01B | -2.35% | 4,074,440 | 940.61M |
| 256 | SGRY | Surgery Partners, Inc. | 2.00B | 4.83% | 2,794,146 | 3.37B |
| 257 | ADRX | ADARx Pharmaceuticals, Inc. | 1.97B | -0.06% | 675,095 | 6.13M |
| 258 | ASTH | Astrana Health, Inc. | 1.97B | 4.39% | 92,787 | 3.84B |
| 259 | BFLY | Butterfly Network, Inc. | 1.97B | -1.20% | 1,760,397 | 112.14M |
| 260 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 3.27% | 218,567 | 1.13B |
| 261 | ALMR | Alamar Biosciences, Inc. | 1.96B | 7.32% | 380,256 | 100.42M |
| 262 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | 6.29% | 1,080,981 | 208.78M |
| 263 | ZBIO | Zenas BioPharma, Inc. | 1.92B | 10.45% | 235,467 | 1.00M |
| 264 | MLYS | Mineralys Therapeutics, Inc. | 1.91B | 3.30% | 413,714 | - |
| 265 | ZYME | Zymeworks Inc. | 1.90B | 5.05% | 1,136,780 | 37.13M |
| 266 | LMAT | LeMaitre Vascular, Inc. | 1.90B | 1.04% | 73,288 | 262.43M |
| 267 | NVAX | Novavax, Inc. | 1.89B | 5.64% | 4,130,680 | 413.80M |
| 268 | ALVO | Alvotech | 1.86B | 3.38% | 1,018,778 | 494.61M |
| 269 | TRVI | Trevi Therapeutics, Inc. | 1.85B | 8.91% | 779,647 | - |
| 270 | XNCR | Xencor, Inc. | 1.85B | 7.07% | 342,455 | 104.97M |
| 271 | PVLA | Palvella Therapeutics, Inc. | 1.85B | 4.16% | 112,095 | - |
| 272 | VIR | Vir Biotechnology, Inc. | 1.82B | 5.58% | 817,502 | 303.23M |
| 273 | SEPN | Septerna, Inc. | 1.82B | 7.23% | 248,665 | 98.88M |
| 274 | NVCR | NovoCure Limited | 1.81B | 4.33% | 753,765 | 699.19M |
| 275 | ESTA | Establishment Labs Holdings Inc. | 1.79B | 3.11% | 156,826 | 245.82M |
| 276 | MAZE | Maze Therapeutics, Inc. | 1.78B | 7.88% | 963,714 | 20.00M |
| 277 | BHVN | Biohaven Ltd. | 1.78B | 3.79% | 707,701 | - |
| 278 | ALHC | Alignment Healthcare, Inc. | 1.77B | 1.79% | 1,184,892 | 4.58B |
| 279 | XRAY | DENTSPLY SIRONA Inc. | 1.76B | 4.81% | 3,405,465 | 3.64B |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.75B | 9.21% | 292,834 | 27.59M |
| 281 | SDGR | Schrödinger, Inc. | 1.74B | 0.43% | 660,220 | 259.04M |
| 282 | KMTS | Kestra Medical Technologies, Ltd. | 1.73B | -1.06% | 433,037 | 106.73M |
| 283 | URGN | UroGen Pharma Ltd. | 1.72B | 3.16% | 242,077 | 188.73M |
| 284 | PSNL | Personalis, Inc. | 1.71B | 0.57% | 1,525,473 | 69.67M |
| 285 | ARDT | Ardent Health, Inc. | 1.71B | 3.42% | 164,399 | 6.41B |
| 286 | ATEC | Alphatec Holdings, Inc. | 1.69B | 4.90% | 633,927 | 815.05M |
| 287 | KLRA | Kailera Therapeutics, Inc. | 1.69B | 13.74% | 688,825 | - |
| 288 | NTLA | Intellia Therapeutics, Inc. | 1.67B | 3.11% | 1,657,424 | 59.51M |
| 289 | BRVE | Braveheart Bio, Inc. | 1.67B | 6.48% | 152,337 | - |
| 290 | OMCL | Omnicell, Inc. | 1.67B | 2.01% | 166,308 | 1.25B |
| 291 | IMCR | Immunocore Holdings plc | 1.67B | 8.41% | 384,252 | 430.78M |
| 292 | GENB | Generate Biomedicines, Inc. | 1.66B | 3.18% | 258,634 | 26.48M |
| 293 | MESO | Mesoblast Limited | 1.65B | 3.43% | 151,860 | 120.25M |
| 294 | CMPS | COMPASS Pathways plc | 1.65B | 7.29% | 1,416,926 | - |
| 295 | NUVB | Nuvation Bio Inc. | 1.64B | 4.13% | 2,552,759 | 169.90M |
| 296 | SNDA | Sonida Senior Living, Inc. | 1.64B | 1.53% | 135,461 | 481.07M |
| 297 | GPCR | Structure Therapeutics Inc. | 1.63B | 4.00% | 789,390 | - |
| 298 | PAHC | Phibro Animal Health Corporation | 1.60B | 0.29% | 64,355 | 1.52B |
| 299 | AMN | AMN Healthcare Services, Inc. | 1.60B | 1.93% | 317,658 | 3.43B |
| 300 | RARE | Ultragenyx Pharmaceutical Inc. | 1.60B | 7.70% | 2,068,063 | 717.00M |
| 301 | AZTA | Azenta, Inc. | 1.58B | 3.79% | 304,357 | 613.81M |
| 302 | COAG | Hemab Therapeutics Holdings, Inc. | 1.57B | 4.61% | 132,884 | - |
| 303 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | 0.50% | 77,854 | 978.38M |
| 304 | AGL | agilon health, inc. | 1.55B | 3.95% | 87,392 | 5.92B |
| 305 | QURE | uniQure N.V. | 1.54B | -0.18% | 515,765 | 18.67M |
| 306 | INVA | Innoviva, Inc. | 1.53B | 0.74% | 189,833 | 440.00M |
| 307 | ANAB | AnaptysBio, Inc. | 1.53B | 3.94% | 295,123 | 106.09M |
| 308 | ABSI | Absci Corporation | 1.53B | 4.33% | 1,535,020 | 1.56M |
| 309 | FRNM | Freenome, Inc. | 1.51B | 11.50% | 459,089 | 35.41M |
| 310 | CERT | Certara, Inc. | 1.48B | 2.54% | 1,038,929 | 421.75M |
| 311 | AAPG | Ascentage Pharma Group International | 1.47B | 2.93% | 1,645 | 94.61M |
| 312 | HCSG | Healthcare Services Group, Inc. | 1.47B | 1.37% | 242,339 | 1.86B |
| 313 | OCUL | Ocular Therapeutix, Inc. | 1.46B | 5.88% | 1,433,096 | 52.06M |
| 314 | TRAX | First Tracks Biotherapeutics, Inc. | 1.46B | 12.46% | 663,578 | - |
| 315 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.06% | 698,676 | 746.16M |
| 316 | PNTG | The Pennant Group, Inc. | 1.43B | 1.03% | 93,030 | 1.10B |
| 317 | RAPP | Rapport Therapeutics, Inc. | 1.43B | 4.34% | 6,006,462 | 20.00M |
| 318 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 8.57% | 1,230,903 | - |
| 319 | ETON | Eton Pharmaceuticals, Inc. | 1.42B | 1.18% | 158,820 | 105.60M |
| 320 | CNMD | CONMED Corporation | 1.41B | 2.37% | 196,847 | 1.37B |
| 321 | KRSA | Korsana Biosciences, Inc. | 1.40B | -1.93% | 53,116 | - |
| 322 | INBX | Inhibrx Biosciences, Inc. | 1.40B | 5.65% | 87,644 | 1.30M |
| 323 | TYRA | Tyra Biosciences, Inc. | 1.39B | 4.50% | 225,387 | - |
| 324 | NUTX | Nutex Health Inc. | 1.35B | 3.12% | 56,704 | 846.72M |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | 4.95% | 4,042,027 | 5.49M |
| 326 | NKTR | Nektar Therapeutics | 1.32B | 5.90% | 398,643 | 54.59M |
| 327 | GHRS | GH Research PLC | 1.31B | 4.68% | 149,278 | - |
| 328 | LBRX | LB Pharmaceuticals Inc | 1.31B | 4.73% | 208,695 | - |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.29B | 3.02% | 111,432 | 804.27M |
| 330 | OPK | OPKO Health, Inc. | 1.28B | 6.52% | 3,050,163 | 587.90M |
| 331 | DMRA | Damora Therapeutics, Inc. | 1.28B | 7.32% | 90,381 | - |
| 332 | SVRA | Savara Inc. | 1.26B | 7.24% | 2,100,101 | - |
| 333 | KARD | Kardigan, Inc. | 1.24B | 2.24% | 208,846 | - |
| 334 | NBTX | Nanobiotix S.A. | 1.23B | 14.82% | 115,603 | 13.15M |
| 335 | INNV | InnovAge Holding Corp. | 1.23B | 1.52% | 216,839 | 989.71M |
| 336 | CRON | Cronos Group Inc. | 1.22B | 1.54% | 566,248 | 179.09M |
| 337 | BCAX | Bicara Therapeutics Inc. | 1.22B | 5.38% | 233,840 | - |
| 338 | DRTS | Alpha Tau Medical Ltd. | 1.21B | 4.13% | 303,348 | - |
| 339 | OMER | Omeros Corporation | 1.20B | 1.65% | 301,719 | 38.42M |
| 340 | ENOV | Enovis Corporation | 1.20B | 4.35% | 455,439 | 2.30B |
| 341 | SNDX | Syndax Pharmaceuticals, Inc. | 1.18B | 1.38% | 1,109,934 | 252.25M |
| 342 | SLN | Silence Therapeutics plc | 1.18B | 0.05% | 10,001,928 | 615.00K |
| 343 | OMDA | Omada Health, Inc. | 1.18B | 6.64% | 483,748 | 309.76M |
| 344 | GDRX | GoodRx Holdings, Inc. | 1.18B | 2.37% | 1,661,948 | 785.23M |
| 345 | BVS | Bioventus Inc. | 1.17B | 2.74% | 156,050 | 581.85M |
| 346 | TNDM | Tandem Diabetes Care, Inc. | 1.16B | 1.40% | 489,625 | 1.04B |
| 347 | VSTM | Verastem, Inc. | 1.14B | 8.99% | 2,452,897 | 87.53M |
| 348 | IRMD | IRADIMED CORPORATION | 1.13B | 0.95% | 24,932 | 86.34M |
| 349 | TDOC | Teladoc Health, Inc. | 1.13B | 8.55% | 2,966,551 | 2.49B |
| 350 | VOR | Vor Biopharma Inc. | 1.13B | 5.49% | 365,617 | - |
| 351 | AORT | Artivion, Inc. | 1.12B | 3.10% | 298,799 | 471.47M |
| 352 | STAA | STAAR Surgical Company | 1.11B | 1.62% | 212,144 | 339.59M |
| 353 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.11B | -0.61% | 104,630 | 730.02M |
| 354 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | 3.97% | 380,064 | 337.34M |
| 355 | REPL | Replimune Group, Inc. | 1.08B | 3.98% | 610,732 | - |
| 356 | AVLN | Avalyn Pharma Inc. | 1.07B | 3.39% | 57,620 | - |
| 357 | JANX | Janux Therapeutics, Inc. | 1.07B | 4.06% | 449,805 | 24.00M |
| 358 | HROW | Harrow, Inc. | 1.06B | 2.58% | 243,886 | 275.59M |
| 359 | AHG | Akso Health Group | 1.06B | -6.77% | 5,843 | 13.83M |
| 360 | CBLL | CeriBell, Inc. | 1.05B | 5.65% | 255,658 | 101.96M |
| 361 | IART | Integra LifeSciences Holdings Corporation | 1.04B | -0.30% | 421,436 | 1.65B |
| 362 | LMRI | Lumexa Imaging Holdings, Inc. | 1.04B | 1.03% | 102,690 | 1.04B |
| 363 | HSTM | HealthStream, Inc. | 1.04B | 1.59% | 38,278 | 321.12M |
| 364 | LTGO | Latigo Biotherapeutics, Inc. | 1.03B | 8.46% | 87,098 | - |
| 365 | CTY | City Therapeutics, Inc. | 1.02B | -4.22% | 459,544 | 14.34M |
| 366 | SPTX | Seaport Therapeutics, Inc. | 1.02B | 6.97% | 53,128 | - |
| 367 | CSTL | Castle Biosciences, Inc. | 1.01B | 3.05% | 96,549 | 357.28M |
| 368 | IMTX | Immatics N.V. | 1.01B | 4.40% | 706,890 | 47.65M |
| 369 | MNKD | MannKind Corporation | 1.00B | 0.81% | 1,183,061 | 393.63M |
| 370 | QDEL | QuidelOrtho Corporation | 986.80M | 12.77% | 1,142,533 | 2.67B |
| 371 | MGTX | MeiraGTx Holdings plc | 969.07M | 6.77% | 328,937 | 397.50M |
| 372 | ANRO | Alto Neuroscience, Inc. | 965.36M | 7.80% | 272,164 | - |
| 373 | GLUE | Monte Rosa Therapeutics, Inc. | 957.22M | 5.25% | 861,692 | 28.73M |
| 374 | CGEM | Cullinan Therapeutics, Inc. | 951.81M | 5.79% | 300,136 | - |
| 375 | BBNX | Beta Bionics, Inc. | 948.08M | 6.95% | 248,532 | 119.01M |
| 376 | JBIO | Jade Biosciences, Inc. | 942.51M | 7.16% | 392,218 | - |
| 377 | ODTX | Odyssey Therapeutics, Inc. | 937.76M | 8.12% | 119,231 | 99.00K |
| 378 | AVBP | ArriVent BioPharma, Inc. | 919.59M | 3.96% | 338,151 | - |
| 379 | SIBN | SI-BONE, Inc. | 913.85M | 3.71% | 229,149 | 213.60M |
| 380 | AKTS | Aktis Oncology, Inc. | 891.58M | 6.09% | 206,671 | 10.06M |
| 381 | KURA | Kura Oncology, Inc. | 886.49M | 6.46% | 823,298 | 77.23M |
| 382 | RIGL | Rigel Pharmaceuticals, Inc. | 884.30M | 1.33% | 172,549 | 276.79M |
| 383 | MLTX | MoonLake Immunotherapeutics | 881.71M | 6.26% | 599,896 | - |
| 384 | SGP | SpyGlass Pharma, Inc. | 881.69M | 7.15% | 59,164 | - |
| 385 | ALMS | Alumis Inc. | 862.69M | 5.13% | 693,733 | 7.40M |
| 386 | SLBT | SL Science Holding Limited | 861.10M | -1.31% | 8,675 | 3.27M |
| 387 | CRVS | Corvus Pharmaceuticals, Inc. | 858.87M | 5.80% | 480,561 | - |
| 388 | ABUS | Arbutus Biopharma Corporation | 856.68M | 2.36% | 931,532 | 181.72M |
| 389 | IVA | Inventiva S.A. | 855.06M | 11.07% | 1,902,625 | 2.81M |
| 390 | HELP | Helus Pharma Inc. | 840.19M | 7.58% | 868,442 | - |
| 391 | INMD | InMode Ltd. | 813.35M | 0.57% | 230,988 | 374.63M |
| 392 | AHCO | AdaptHealth Corp. | 810.46M | 3.32% | 1,084,439 | 3.36B |
| 393 | GMRS | GMR Solutions Inc. | 799.76M | 3.11% | 302,846 | 5.88B |
| 394 | ARDX | Ardelyx, Inc. | 797.40M | 3.56% | 1,829,267 | 450.89M |
| 395 | GERN | Geron Corporation | 787.03M | 2.08% | 1,938,409 | 204.56M |
| 396 | VREX | Varex Imaging Corporation | 777.42M | 0.24% | 292,560 | 865.00M |
| 397 | APMD | Apnimed, Inc. | 771.42M | 11.66% | 149,049 | 115.12M |
| 398 | OBX | Obsidian Therapeutics, Inc. | 769.69M | 4.36% | 208,574 | - |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 755.29M | 0.83% | 268,230 | 808.21M |
| 400 | IMMX | Immix Biopharma, Inc. | 737.01M | 8.15% | 550,176 | - |
| 401 | IAM | Iambic Therapeutics, Inc. | 736.85M | -4.87% | 738,057 | 18.25M |
| 402 | ANNX | Annexon, Inc. | 732.72M | -3.62% | 3,491,879 | - |
| 403 | PHR | Phreesia, Inc. | 725.61M | 3.63% | 372,961 | 507.79M |
| 404 | FDMT | 4D Molecular Therapeutics, Inc. | 724.80M | 6.75% | 352,799 | 92.01M |
| 405 | SANA | Sana Biotechnology, Inc. | 721.46M | 4.78% | 2,398,727 | - |
| 406 | OABI | OmniAb, Inc. | 719.68M | 5.54% | 1,417,876 | 38.46M |
| 407 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.93M | 3.23% | 873,466 | 41.47M |
| 408 | CTKB | Cytek Biosciences, Inc. | 710.36M | 4.10% | 278,919 | 206.71M |
| 409 | PRME | Prime Medicine, Inc. | 704.50M | 3.39% | 2,051,281 | 4.07M |
| 410 | SGMT | Sagimet Biosciences Inc. | 700.58M | 11.51% | 1,440,457 | - |
| 411 | AURA | Aura Biosciences, Inc. | 694.82M | 6.52% | 435,084 | - |
| 412 | ACHV | Achieve Life Sciences, Inc. | 694.59M | 2.20% | 877,221 | - |
| 413 | SLDB | Solid Biosciences Inc. | 692.68M | 9.12% | 873,460 | - |
| 414 | DSGN | Design Therapeutics, Inc. | 689.65M | 3.57% | 313,958 | - |
| 415 | ANL | Adlai Nortye Group Ltd. | 682.62M | 2.12% | 149,512 | 18.06M |
| 416 | DNA | Ginkgo Bioworks Holdings, Inc. | 681.15M | 0.45% | 1,389,021 | 132.42M |
| 417 | WVE | Wave Life Sciences, Inc. | 680.80M | 8.99% | 2,053,453 | 65.37M |
| 418 | PHAR | Pharming Group N.V. | 678.44M | 4.28% | 3,691 | 366.48M |
| 419 | STLN | Starling Oncology, Inc. | 674.68M | 2.48% | 596,807 | 587.24M |
| 420 | CADL | Candel Therapeutics, Inc. | 671.83M | 6.94% | 670,862 | - |
| 421 | NVCT | Nuvectis Pharma, Inc. | 671.18M | 8.76% | 71,715 | - |
| 422 | AVTX | Avalo Therapeutics, Inc. | 668.23M | 7.51% | 550,877 | 59.00K |
| 423 | GYRE | Gyre Therapeutics, Inc. | 668.01M | 3.45% | 42,698 | 109.82M |
| 424 | OLMA | Olema Pharmaceuticals, Inc. | 658.86M | 5.91% | 974,936 | - |
| 425 | ATTO | Attovia Therapeutics, Inc. | 653.27M | 3.02% | 270,522 | 1.80M |
| 426 | MDXG | MiMedx Group, Inc. | 631.14M | -1.14% | 651,372 | 355.17M |
| 427 | PACB | Pacific Biosciences of California, Inc. | 630.99M | 10.33% | 5,343,852 | 159.27M |
| 428 | CLYM | Climb Bio, Inc. | 626.06M | 12.02% | 541,665 | - |
| 429 | AVR | Anteris Technologies Global Corp. | 625.91M | 3.88% | 428,548 | 2.24M |
| 430 | ZVRA | Zevra Therapeutics, Inc. | 621.75M | 3.05% | 189,167 | 136.07M |
| 431 | IRWD | Ironwood Pharmaceuticals, Inc. | 603.95M | 2.67% | 876,276 | 389.32M |
| 432 | KIDS | OrthoPediatrics Corp. | 596.61M | 3.72% | 44,356 | 252.72M |
| 433 | WEAV | Weave Communications, Inc. | 592.39M | 0.07% | 1,268,779 | 257.79M |
| 434 | CRMD | CorMedix Inc. | 588.48M | 2.30% | 575,621 | 462.25M |
| 435 | PHAT | Phathom Pharmaceuticals, Inc. | 584.61M | 4.99% | 335,581 | 239.66M |
| 436 | STTK | Shattuck Labs, Inc. | 582.11M | 8.01% | 1,082,589 | 1.00M |
| 437 | CBIO | Crescent Biopharma, Inc. | 571.39M | 8.01% | 135,813 | 11.88M |
| 438 | SOPH | SOPHiA GENETICS SA | 568.65M | 2.93% | 240,802 | 86.17M |
| 439 | FLGT | Fulgent Genetics, Inc. | 565.71M | 2.29% | 73,101 | 323.93M |
| 440 | ETRA | Electra Therapeutics, Inc. | 563.96M | 4.36% | 73,908 | - |
| 441 | ENTX | Entera Bio Ltd. | 561.77M | 9.86% | 578,805 | 42.00K |
| 442 | DBVT | DBV Technologies S.A. | 560.42M | 5.91% | 178,421 | 5.04M |
| 443 | MYGN | Myriad Genetics, Inc. | 557.16M | 38.36% | 20,680,765 | 806.60M |
| 444 | PBYI | Puma Biotechnology, Inc. | 556.46M | 5.58% | 175,606 | 231.24M |
| 445 | EVH | Evolent Health, Inc. | 551.73M | 8.93% | 610,053 | 2.10B |
| 446 | CTMX | CytomX Therapeutics, Inc. | 551.29M | 8.12% | 1,933,166 | 18.30M |
| 447 | DRUG | Bright Minds Biosciences Inc. | 550.38M | 5.44% | 70,661 | - |
| 448 | EVO | Evotec SE | 550.29M | 4.93% | 72,522 | 819.47M |
| 449 | ACRS | Aclaris Therapeutics, Inc. | 549.05M | 7.18% | 1,487,084 | 8.22M |
| 450 | FTH | Faeth Therapeutics, Inc. | 541.10M | 7.72% | 437,274 | - |
| 451 | VALN | Valneva SE | 530.81M | 3.01% | 9,755 | 163.30M |
| 452 | TCMD | Tactile Systems Technology, Inc. | 529.61M | 2.86% | 117,282 | 350.31M |
| 453 | DCTH | Delcath Systems, Inc. | 514.24M | 3.13% | 132,878 | 95.42M |
| 454 | AQST | Aquestive Therapeutics, Inc. | 513.34M | 6.79% | 1,375,766 | 54.09M |
| 455 | NGNE | Neurogene Inc. | 509.09M | 5.25% | 114,286 | 925.00K |
| 456 | EPRX | Eupraxia Pharmaceuticals Inc. | 508.16M | 10.50% | 593,503 | - |
| 457 | SSII | SS Innovations International, Inc. | 506.98M | 3.27% | 15,759 | 52.40M |
| 458 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 459 | ARVN | Arvinas, Inc. | 500.86M | 5.51% | 243,620 | 316.70M |
| 460 | ANGO | AngioDynamics, Inc. | 497.29M | 3.82% | 588,029 | 325.38M |
| 461 | RGNX | REGENXBIO Inc. | 497.08M | 5.31% | 619,169 | 174.48M |
| 462 | EOLS | Evolus, Inc. | 493.40M | 1.49% | 149,843 | 316.49M |
| 463 | MNPR | Monopar Therapeutics Inc. | 493.21M | 2.81% | 32,352 | - |
| 464 | BWAY | BrainsWay Ltd. | 486.19M | 0.71% | 50,187 | 60.70M |
| 465 | MASS | 908 Devices Inc. | 481.12M | 1.84% | 178,518 | 60.84M |
| 466 | DMAC | DiaMedica Therapeutics Inc. | 476.43M | 12.26% | 89,424 | - |
| 467 | SGHT | Sight Sciences, Inc. | 471.55M | 3.63% | 142,129 | 83.38M |
| 468 | BLSM | BlossomHill Therapeutics, Inc. | 469.46M | 4.31% | 21,759 | - |
| 469 | MPLT | MapLight Therapeutics, Inc. | 464.06M | 4.37% | 162,336 | - |
| 470 | OVID | Ovid Therapeutics Inc. | 463.83M | 9.45% | 3,037,934 | 1.58M |
| 471 | ALLO | Allogene Therapeutics, Inc. | 462.96M | 3.08% | 2,859,299 | 4.64M |
| 472 | OCS | Oculis Holding AG | 462.68M | 2.39% | 159,840 | 1.45M |
| 473 | NPCE | NeuroPace, Inc. | 460.63M | 5.09% | 55,599 | 106.99M |
| 474 | CERS | Cerus Corporation | 460.48M | 2.93% | 853,705 | 221.55M |
| 475 | NRC | NRC Health | 460.31M | 1.66% | 23,940 | 140.00M |
| 476 | KMDA | Kamada Ltd. | 453.45M | 3.02% | 46,579 | 191.85M |
| 477 | EIKN | Eikon Therapeutics, Inc. | 453.09M | 8.64% | 185,403 | - |
| 478 | TLRY | Tilray Brands, Inc. | 452.45M | 1.82% | 1,982,447 | 963.10M |
| 479 | PROK | ProKidney Corp. | 450.46M | 6.81% | 997,917 | 818.00K |
| 480 | ALT | Altimmune, Inc. | 445.45M | 2.69% | 1,162,075 | 31.00K |
| 481 | PRTA | Prothena Corporation plc | 438.93M | 0.83% | 227,977 | 54.53M |
| 482 | SENS | Senseonics Holdings, Inc. | 436.21M | 2.93% | 154,881 | 48.55M |
| 483 | ASMB | Assembly Biosciences, Inc. | 434.29M | 5.80% | 105,422 | 74.85M |
| 484 | AUTL | Autolus Therapeutics plc | 433.84M | 2.52% | 1,415,043 | 117.39M |
| 485 | RCEL | AVITA Medical, Inc. | 431.12M | 6.09% | 212,341 | 75.63M |
| 486 | YDES | YD Bio Limited | 430.65M | -0.65% | 27,690 | 1.24M |
| 487 | TECX | Tectonic Therapeutic, Inc. | 429.70M | 3.92% | 83,863 | - |
| 488 | AGMB | AgomAb Therapeutics NV | 428.46M | 5.71% | 17,220 | - |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 426.63M | 1.42% | 717,262 | 116.93M |
| 490 | SRTA | Strata Critical Medical, Inc. | 415.79M | 3.52% | 338,870 | 255.98M |
| 491 | EDIT | Editas Medicine, Inc. | 406.22M | 9.30% | 1,274,960 | 47.01M |
| 492 | TKNO | Alpha Teknova, Inc. | 405.88M | 11.18% | 128,224 | 43.70M |
| 493 | AUNA | Auna S.A. | 402.63M | 1.12% | 86,013 | 1.37B |
| 494 | OFIX | Orthofix Medical Inc. | 400.40M | 2.50% | 130,969 | 833.19M |
| 495 | TRXB | TRex Bio, Inc. | 399.12M | 0.17% | 41,616 | - |
| 496 | ZURA | Zura Bio Limited | 395.30M | 8.27% | 2,194,624 | - |
| 497 | CAPR | Capricor Therapeutics, Inc. | 392.44M | 1.50% | 1,208,500 | 11.13M |
| 498 | RZLT | Rezolute, Inc. | 392.31M | 1.08% | 685,010 | - |
| 499 | SI | Shoulder Innovations, Inc. | 391.08M | 2.93% | 21,296 | 60.06M |
| 500 | CYH | Community Health Systems, Inc. | 389.64M | 4.17% | 654,421 | 11.98B |